Classic Follicular Lymphoma — Trials

Classic Follicular Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

194 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 12%
Top sponsor: City of Hope Medical Center
Termination share: 32.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (44)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06575686	Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma	suspended	Phase 2	33	City of Hope Medical CenterOTHER	1	Jan 21, 2026	clinicaltrials

Data updated 22 days agoSource updated Jan 21, 2026source: clinicaltrials